134 related articles for article (PubMed ID: 36166917)
1. Paradoxical GH increase during oral glucose load may predict overall remission in acromegalic patients.
Düğer H; Bostan H; Deryol HY; İmga NN; Uçan B; Çalapkulu M; Hepşen S; Akhanlı P; Gül Ü; Sencar ME; Çakal E; Özdemir Ş; Kızılgül M
Growth Horm IGF Res; 2022 Dec; 67():101501. PubMed ID: 36166917
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics of Acromegalic Patients With Paradoxical GH Response to Oral Glucose Load.
Mukai K; Otsuki M; Tamada D; Kitamura T; Hayashi R; Saiki A; Goto Y; Arita H; Oshino S; Morii E; Saitoh Y; Shimomura I
J Clin Endocrinol Metab; 2019 May; 104(5):1637-1644. PubMed ID: 30476255
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical GH Increase During OGTT Is Associated With First-Generation Somatostatin Analog Responsiveness in Acromegaly.
Scaroni C; Albiger N; Daniele A; Dassie F; Romualdi C; Vazza G; Regazzo D; Ferraù F; Barresi V; Maffeis V; Gardiman MP; Cannavò S; Maffei P; Ceccato F; Losa M; Occhi G
J Clin Endocrinol Metab; 2019 Mar; 104(3):856-862. PubMed ID: 30285115
[TBL] [Abstract][Full Text] [Related]
4. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and treatment responsiveness of patients with acromegaly and a paradoxical GH increase to oral glucose load.
Atquet V; Alexopoulou O; Maiter D
Eur J Endocrinol; 2021 Jul; 185(2):313-321. PubMed ID: 34085950
[TBL] [Abstract][Full Text] [Related]
6. Value of Early Post-Operative Growth Hormone Testing in Predicting Long-Term Remission and Residual Disease after Transsphenoidal Surgery for Acromegaly.
Wang YY; Waqar M; Abou-Zeid A; Kearney T; Caputo C; Davis J; Trainer P; Higham C; Roncaroli F; Gnanalingham KK
Neuroendocrinology; 2022; 112(4):345-357. PubMed ID: 34052822
[TBL] [Abstract][Full Text] [Related]
7. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[TBL] [Abstract][Full Text] [Related]
8. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
Elias PC; Lugao HB; Pereira MC; Machado HR; Castro Md; Moreira AC
Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
[TBL] [Abstract][Full Text] [Related]
9. Value of early postoperative random growth hormone levels and nadir growth hormone levels after oral glucose tolerance testing in acromegaly.
Rotermund R; Burkhardt T; Rohani Z; Jung R; Aberle J; Flitsch J
Growth Horm IGF Res; 2018 Aug; 41():64-70. PubMed ID: 29555234
[TBL] [Abstract][Full Text] [Related]
10. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
[TBL] [Abstract][Full Text] [Related]
11. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
[TBL] [Abstract][Full Text] [Related]
12. Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.
Freda PU; Nuruzzaman AT; Reyes CM; Sundeen RE; Post KD
J Clin Endocrinol Metab; 2004 Feb; 89(2):495-500. PubMed ID: 14764751
[TBL] [Abstract][Full Text] [Related]
13. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly.
Carmichael JD; Bonert VS; Mirocha JM; Melmed S
J Clin Endocrinol Metab; 2009 Feb; 94(2):523-7. PubMed ID: 19033371
[TBL] [Abstract][Full Text] [Related]
14. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.
Kim EH; Oh MC; Lee EJ; Kim SH
Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418
[TBL] [Abstract][Full Text] [Related]
15. Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly.
Biermasz NR; Smit JW; van Dulken H; Roelfsema F
Clin Endocrinol (Oxf); 2002 Mar; 56(3):313-9. PubMed ID: 11940042
[TBL] [Abstract][Full Text] [Related]
16. Is GH nadir during OGTT a reliable test for diagnosis of acromegaly in patients with abnormal glucose metabolism?
Dobri G; Niwattisaiwong S; Bena JF; Gupta M; Kirwan J; Kennedy L; Hamrahian AH
Endocrine; 2019 Apr; 64(1):139-146. PubMed ID: 30415402
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment.
Reimondo G; Bondanelli M; Ambrosio MR; Grimaldi F; Zaggia B; Zatelli MC; Allasino B; Laino F; Aroasio E; Termine A; Conton P; Paoletta A; Demenis E; Uberti ED; Terzolo M
Endocrine; 2014 Feb; 45(1):122-7. PubMed ID: 23794116
[TBL] [Abstract][Full Text] [Related]
18. The Preoperative Paradoxical GH Response to Oral Glucose Load Predicts a low Risk of Recurrence in Acromegaly.
Losa M; Garbin E; Calcagnile R; Voltan G; Ceccato F; Scaroni C; Occhi G; Mortini P
J Clin Endocrinol Metab; 2024 Jun; ():. PubMed ID: 38878276
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly.
Pekic S; Doknic M; Miljic D; Joksimovic M; Glodic J; Djurovic M; Dieguez C; Casanueva F; Popovic V
Eur J Endocrinol; 2006 May; 154(5):659-66. PubMed ID: 16645012
[TBL] [Abstract][Full Text] [Related]
20. Gender and age in the biochemical assessment of cure of acromegaly.
Freda PU; Landman RE; Sundeen RE; Post KD
Pituitary; 2001 Aug; 4(3):163-71. PubMed ID: 12138989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]